He-San Luo

Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

Xue Bai, Dehua Wu, Si-Cong Ma et al. · Journal for ImmunoTherapy of Cancer · 2020 · 63 citations · Full text

Medicine, Immunology, Oncology +17

Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer

He-San Luo, Weizhen Huang, Sheng‐Xi Wu et al. · Radiation Oncology · 2021 · 49 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis

He-San Luo, Hong-Yao Xu, Ze-Sen Du et al. · Radiation Oncology · 2019 · 44 citations · Full text

Medicine, Oncology, Radiation Oncology +16

A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer

He-San Luo, Shao-Fu Huang, Hong-Yao Xu et al. · Radiation Oncology · 2020 · 43 citations · Full text

Medicine, Oncology, Radiology +17

Preoperative Administration of Olive Oil Reduces Chylothorax After Minimally Invasive Esophagectomy

Ze-Sen Du, Xu‐Yuan Li, He-San Luo et al. · The Annals of Thoracic Surgery · 2018 · 34 citations · Full text

Medicine, Perioperative Medicine, Surgery +8